Nadine Beauger

Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada.

BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun.

Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.

Césart Création, Inc. is a Canadian company that provides business consulting, marketing services, computerized animation, and integrated software and applications. The company was founded by Yves Eric Laliberté and is based in Montréal, Canada. Part of BCE, Inc., Césart Création, Inc. offers a range of services to help businesses with their marketing and software needs. Césart Création, Inc. was acquired by Bell Zinc Corp on December 01, 2001.

StreamTheWorld, Inc. provides Internet streaming solutions for audio and video content. Its integrated streaming solutions enable radio and television broadcasters generate record online revenues. The company was founded in 2005 and is headquartered in Montréal, Canada.

Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada.

Triton Digital, Inc. provides digital audio technology for the audio industry. Its solutions include podcasting, audio streaming, audio advertising, audience measurement, and audience engagement. The company was founded by Michael Agovino and Neal Schore in 2006 and is headquartered in Sherman Oaks, CA.

Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada.

Gestion Univalor LP Provides research services. Its services include researcher services, and industry and investors services. The company was founded in 2001 and is headquartered in Montreal, Canada.

Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada.

Triton Digital Media provides digital audio technologies and advertising platforms. The company was founded by Neal Schore and Michael Agovino in 2006 and is headquartered in Sherman Oaks, CA.

Nowo Communications SA provides telecommunication services. It offers cable network, Internet connection, television access, and voice services. The company was founded in 1993 and is headquartered in Palmela, Portugal.

TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada.

The Centre for the Commercialization of Antibodies & Biologics is a Canadian company that manufactures pharmaceutical products.

Omniabio, Inc. is a subsidiary of CCRM and is a contract development and manufacturing organization producing gene-modified cells and viral vectors, compliant with current good manufacturing practices standards. The private company's facility, located at McMaster Innovation Park in Hamilton, Canada, will be the first commercial-scale CDMO dedicated to cell and gene therapies and is expected to be the largest facility of its kind. The company is based in Hamilton, Canada and is supported by the government of Ontario via the Invest Ontario Fund. Omniabio will anchor a biomanufacturing center of excellence and will open in three phases between 2024 and 2026. The CEO of the Canadian company is Mitchel Sivilotti.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada.

The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada.

20/20 Vision Centers, Inc. provides lasik surgery services. It offers refractive laser surgery that treats nearsightedness, farsightedness and astigmatism with incisions. It uses technology such as Nidek and Visx Star S3 Laser, Orbscan, and Hansatome Microkeratome. The company is headquartered in Murray, UT.

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada.

Elucidia Group, Inc. is a Canadian company that specializes in cybersecurity. The company is based in Québec, Canada. The company provides solutions that make cybersecurity simpler, more accessible, and more inclusive, ultimately delivering effective results. It was founded by Martin Berthiaume, and the CEO is Yves Eric Laliberté.

Worximity Technology, Inc. develops a dashboard that allows businesses to monitor and transform the manufacturing processes in real-time. It offers data collection, downtime causes tracking, and continuous improvement solutions. The company was founded by Yannick Desmarais in 2011 and is headquartered in Montreal, Canada.

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.

Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA.

Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada.